Profile
Full Name
KALA BIO, Inc.Ticker Symbol
KALAExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 20, 2017Indexes
Not includedWebsite
http://www.kalarx.comEmployees
38Key Details
Price
$3.49(+3.56%)
Market cap
$22.52M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$10.15(+41.50% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Kala Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 4, 25 HC Wainwright & Co.
BuyFeb 13, 25 HC Wainwright & Co.
BuyNov 15, 24 HC Wainwright & Co.
BuyAug 19, 24 Oppenheimer
OutperformMay 17, 24 HC Wainwright & Co.
BuyApr 2, 24 HC Wainwright & Co.
BuyApr 1, 24 Oppenheimer
OutperformNov 17, 23 HC Wainwright & Co.
BuyAug 11, 23 HC Wainwright & Co.
BuyMay 10, 23 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Kala Pharmaceuticals?
- Does Kala Pharmaceuticals pay dividends?
- What sector is Kala Pharmaceuticals in?
- What industry is Kala Pharmaceuticals in?
- What country is Kala Pharmaceuticals based in?
- When did Kala Pharmaceuticals go public?
- Is Kala Pharmaceuticals in the S&P 500?
- Is Kala Pharmaceuticals in the NASDAQ 100?
- Is Kala Pharmaceuticals in the Dow Jones?
- When was Kala Pharmaceuticals's last earnings report?
- When does Kala Pharmaceuticals report earnings?
- Should I buy Kala Pharmaceuticals stock now?
What is the ticker symbol for Kala Pharmaceuticals?
The ticker symbol for Kala Pharmaceuticals is NASDAQ:KALA
Does Kala Pharmaceuticals pay dividends?
No, Kala Pharmaceuticals does not pay dividends
What sector is Kala Pharmaceuticals in?
Kala Pharmaceuticals is in the Healthcare sector
What industry is Kala Pharmaceuticals in?
Kala Pharmaceuticals is in the Biotechnology industry
What country is Kala Pharmaceuticals based in?
Kala Pharmaceuticals is headquartered in United States
When did Kala Pharmaceuticals go public?
Kala Pharmaceuticals's initial public offering (IPO) was on July 20, 2017
Is Kala Pharmaceuticals in the S&P 500?
No, Kala Pharmaceuticals is not included in the S&P 500 index
Is Kala Pharmaceuticals in the NASDAQ 100?
No, Kala Pharmaceuticals is not included in the NASDAQ 100 index
Is Kala Pharmaceuticals in the Dow Jones?
No, Kala Pharmaceuticals is not included in the Dow Jones index
When was Kala Pharmaceuticals's last earnings report?
Kala Pharmaceuticals's most recent earnings report was on Mar 31, 2025
When does Kala Pharmaceuticals report earnings?
The next expected earnings date for Kala Pharmaceuticals is May 14, 2025
Should I buy Kala Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions